He interviewed Eli Lilly and Company (NYSE:LLY)'s CEO David Ricks as part of the coverage, and commented on the stock before and after the interview. Here's what Cramer said: "Yeah, I think that ...

We recently published a list of Jim Cramer Discussed These 18 Stocks As Inflation Dropped. In this article, we are going to ...

Good afternoon, everybody. I'm Chris Schott at JPMorgan and it's my pleasure to be hosting this fireside chat today with Dave Ricks, Chairman and CEO of Eli Lilly. It's been a tremendous few years ...

Regarding the guidance approach, the CEO noted, "The scale of this business ... the 3Q results and guidance update." Price Action: LLY stock is up 0.59% at $749.28 at the last check on Wednesday.

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 472.57% and ...

The biotech has named Jamie Coleman its chief commercial officer, per a Monday announcement, putting her in charge of the ...

Eli Lilly and Company (NYSE: LLY) will attend the 43rd Annual J.P. Morgan Healthcare Conference, Jan. 13-16, 2025. David A. Ricks, Lilly chair and CEO, will participate in a fireside chat on ...

Eli Lilly's diverse portfolio shows broad growth, with significant contributions from oncology and other therapeutic areas.

CEO David Ricks reported that the U.S. weight ... Strong 2025 Revenue Guidance On a positive note, LLY predicted that it would generate 2025 revenue of $58 billion to $61 billion.

Also Read: Eli Lilly Adjusts Outlook, CEO David Ricks Explains Revenue Shortfall Omvoh works ... of additional treatment (two ...